Taipei, Taiwan / Düsseldorf, Germany, November 14th, 2022 – iXensor Co., Ltd. (6734. TWO) iXensor, the pioneer of mobile health, today announces that a partnership has been established with Innova Medical Group. Innova Medical Group is a leading global scale-up platform for rapid screening and diagnosis, with notably more than…
iXensor, the pioneer of mobile health, today announced its “PixoTest® COVID -19 Antigen Self-Test Kit” has been granted by Taiwan FDA for EUA, in response to the recent peak of the epidemic and the new quarantine mandate of 0+7 taking effect on Oct 13th, Taiwan will officially enter the era…
From Aug 31st to Sep 2nd, iXensor will present at booth 2P16 of Southeast Asia’s most established trade fair for the medical and healthcare industry – MEDICAL FAIR ASIA 2022. iXensor will exhibit its Taiwan Excellence Gold Award PixoTest® POCT System for infectious and cardiometabolic diseases, and Eveline®, the smartphone-based…
PixoTech® licensing shifted in as iXensor’s new growth engine to meet self-testing strong demand in the post-pandemic era Taipei, Taiwan / Osaka, Japan, April 27th, 2022 – iXensor Co., Ltd. (6734. TWO) iXensor, the pioneer of mobile health, today announced that Rohto Pharmaceutical Co., Ltd, a multinational pharmaceutical corporation headquartered in Japan, has…
iXensor has recently been covered in AFP, Yahoo Finance, and other media about the computer vision-powered PixoTest® COVID-19 Antigen Test can effectively detect Omicron (B.1.1.529) and all major SARS-CoV-2 variants. Read the full news here: https://reurl.cc/Mb1A9m
Taipei, Taiwan – December 22nd, 2021 – iXensor Co., Ltd. (6734.TWO) iXensor, the pioneer of mobile health, declares that its computer vision-powered PixoTest® COVID-19 Antigen Test effectively detects all major SARS-CoV-2 variants including Omicron (B.1.1.529) after completing two validation studies. In response to emerging new waves of the covid-19 pandemic…
Taipei Taiwan – November 24th, 2021 – iXensor Co., Ltd. (6734.TWO) iXensor, the pioneer of mobile health, wins the Taiwan Excellence Gold Award for its computer vision-aided PixoTest® COVID-19 Antigen Test, together with its enterprise PixoHealth Pass Solution. The integrated point-of-care diagnostics and health management SaaS product offers an…
iXensor latest Eveline·Care service enables fertility consultants to access a patient’s fertility data and remotely monitor their conditions in real-time. MobiHealth News and other media have covered this telehealth fertility tool as below: “The Eveline·Care telehealth service enables fertility consultants to access patient’s ovulation test data and recorded symptoms via a…
Palo Alto, California / Taipei, Taiwan, September 14th, 2021 – iXensor Co., Ltd. (6734.TWO) iXensor, the pioneer of mobile health, launches its new Eveline·Care service, effectively turning the smartphone-based Eveline Ovulation Predictor Kit (OPK) into a telehealth-enabled fertility monitoring system. This telehealth service is anticipated by OB-GYN practitioners and highly…
iXensor’s recently been mentioned again by BBC StoryWorks as one of the cutting-edge medtech companies from Taiwan! Leveraging its ICT strength and rich data from its national health insurance program, Taiwan is emerging as the innovation hub of the biomedical industry. Read more: https://reurl.cc/1YaemQ
